CELLDEX THERAPEUTICS INC (CLDX) Stock Cash Flow
NASDAQ:CLDX - Nasdaq - US15117B2025 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -154.08M | -141.43M | -112.33M | -70.51M | -59.78M | |||
| Depreciation Amortization | 3.12M | 3.01M | 2.90M | 3.07M | 3.93M | |||
| Change In Working Capital | -24.00M | 13.46M | -3.90M | -1.05M | -300.00K | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 17.12M | 17.67M | 9.60M | 7.59M | 15.75M | |||
| OPERATING CASH FLOW | -157.83M | -107.29M | -103.73M | -60.91M | -40.40M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.83M | -1.82M | -1.83M | -1.25M | -1.55M | |||
| Other Investing Activity | -483.51M | -103.96M | 91.77M | -214.91M | -96.67M | |||
| INVESTING CASH FLOW | -485.34M | -105.78M | 89.94M | -216.16M | -98.22M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Stock Issued/Repurchased | N/A | 216.22M | 0.00 | 269.89M | 170.79M | |||
| Other Financing Activity | 9.92M | 2.24M | 4.08M | 2.48M | 430.00K | |||
| FINANCING CASH FLOW | 658.44M | 218.46M | 4.08M | 272.37M | 171.23M | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | |||
| CHANGE IN CASH | 15.27M | 5.39M | -9.71M | -4.70M | 32.61M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -157.83M | -107.29M | -103.73M | -60.91M | -40.40M | |||
| Capital Expenditure | -1.83M | -1.82M | -1.83M | -1.25M | -1.55M | |||
| FREE CASH FLOW | -159.66M | -109.11M | -105.56M | -62.16M | -41.95M | |||
All data in USD